Pediatric Obesity: Should We Prescribe GLP-1 Agonists for Adolescents
Additionally, Semaglutide suppresses the release of glucagon, a hormone that increases blood glucose levels, further aiding in the stabilization of blood sugar
Blood banks may ask follow-up questions about side effects, how long you've been stable on your dose, or whether you have any diabetes complications
Unlike the starting dose used to help your body adjust to the medication, your maintenance dose provides the ongoing therapeutic benefits you need
The cardiovascular benefits of GLP-1-RAs arise primarily through indirect systemic mechanisms, with limited evidence supporting direct effects on cardiomyocytes ( Figure 1 )
10.1136/heartjnl-2015-308826 98 SuzukiT.YazakiY.VoorsA